KLRD1 and cancer: This review provides a comprehensive overview of the NK cell receptors that are mainly used as NK cell immunotherapy targets, with a focus on the ongoing preclinical and clinical trials involving the manipulation of activating receptors, inhibitory receptors, and other pivotal factors of NK cells for monotherapy or combinational approaches in cancer immunotherapy.